This site is intended for UK healthcare professionals

 

Featured videos #1 videos

Sponsored

Studies report up to 18% (n/N = 9/49) of patients aged ≥60 years old with heart failure with preserved ejection fraction (HFpEF) had transthyretin amyloid cardiomyopathy (ATTR-CM), one of the main types of cardiac amyloidosis.1 Clinical expert Dr Kate Gatenby highlights this and gives an overview of the causes, diagnosis and best practices in the management of patients with ATTR-CM.

Promotional video developed and funded by Pfizer Ltd intended for UK HCPs only.

PP-VYN-GBR-2016 | March 2026

GPs Neil Paul and Martin Godfrey discuss the functions and roles of artificial intelligence (AI) and how digital healthcare may revolutionise and improve future general practice. In this fascinating and hugely relevant conversation, the doctors explore how AI can support clinicians in contemporary primary care for cardiovascular health.
The increasing toxicity profile of cancer treatments has resulted in a growing demand for specialist cardio-oncology care. Listen to Dr SivaTharshini Ramalingam discuss how hospitals and community practitioners can work together to identify, treat and improve the quality of life for people experiencing cardiac dysfunction as a consequence of cancer treatments. She also explains which drugs are most commonly used, their key toxicities and reg flags for care.
 

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.